nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—SLC22A5—Crohn's disease	0.25	0.604	CbGaD
Epinephrine—TNF—Crohn's disease	0.163	0.396	CbGaD
Epinephrine—Carbidopa—Mesalazine—Crohn's disease	0.122	0.24	CrCrCtD
Epinephrine—Methyldopa—Mesalazine—Crohn's disease	0.106	0.207	CrCrCtD
Epinephrine—Dopamine—Mesalazine—Crohn's disease	0.106	0.207	CrCrCtD
Epinephrine—Droxidopa—Mesalazine—Crohn's disease	0.106	0.207	CrCrCtD
Epinephrine—L-DOPA—Mesalazine—Crohn's disease	0.0703	0.138	CrCrCtD
Epinephrine—PAH—gall bladder—Crohn's disease	0.00156	0.22	CbGeAlD
Epinephrine—ADRBK1—mouth—Crohn's disease	0.00106	0.149	CbGeAlD
Epinephrine—ADRBK1—smooth muscle tissue—Crohn's disease	0.000594	0.0837	CbGeAlD
Epinephrine—ADRBK1—lymphoid tissue—Crohn's disease	0.000475	0.0669	CbGeAlD
Epinephrine—ADRBK1—digestive system—Crohn's disease	0.000469	0.0661	CbGeAlD
Epinephrine—TNF—lymph node—Crohn's disease	0.000467	0.0657	CbGeAlD
Epinephrine—ADRA1D—epithelium—Crohn's disease	0.000355	0.05	CbGeAlD
Epinephrine—SLC22A2—digestive system—Crohn's disease	0.000289	0.0407	CbGeAlD
Epinephrine—Norepinephrine—SLC22A5—Crohn's disease	0.000273	0.518	CrCbGaD
Epinephrine—ADRBK1—lymph node—Crohn's disease	0.000268	0.0378	CbGeAlD
Epinephrine—Dopamine—SLC22A5—Crohn's disease	0.000254	0.482	CrCbGaD
Epinephrine—Skin necrosis—Mesalazine—Crohn's disease	0.00024	0.0874	CcSEcCtD
Epinephrine—ADRA1A—epithelium—Crohn's disease	0.000204	0.0287	CbGeAlD
Epinephrine—SLC22A5—skin of body—Crohn's disease	0.000177	0.0249	CbGeAlD
Epinephrine—Nephropathy—Mesalazine—Crohn's disease	0.000176	0.0641	CcSEcCtD
Epinephrine—ADRA2C—mammalian vulva—Crohn's disease	0.000169	0.0238	CbGeAlD
Epinephrine—ADRA1A—lymphoid tissue—Crohn's disease	0.000157	0.0221	CbGeAlD
Epinephrine—Local reaction—Mesalazine—Crohn's disease	0.000151	0.0551	CcSEcCtD
Epinephrine—SLC22A5—digestive system—Crohn's disease	0.000142	0.02	CbGeAlD
Epinephrine—ADRA2A—mammalian vulva—Crohn's disease	0.000135	0.019	CbGeAlD
Epinephrine—CYP1A2—digestive system—Crohn's disease	0.000128	0.0181	CbGeAlD
Epinephrine—CYP2C9—digestive system—Crohn's disease	0.000122	0.0172	CbGeAlD
Epinephrine—CYP3A4—digestive system—Crohn's disease	9.29e-05	0.0131	CbGeAlD
Epinephrine—ADRA2C—lymph node—Crohn's disease	8.45e-05	0.0119	CbGeAlD
Epinephrine—SLC22A5—lymph node—Crohn's disease	8.09e-05	0.0114	CbGeAlD
Epinephrine—Skin exfoliation—Mesalazine—Crohn's disease	8e-05	0.0291	CcSEcCtD
Epinephrine—Disorientation—Mesalazine—Crohn's disease	6.8e-05	0.0248	CcSEcCtD
Epinephrine—ADRA2A—lymph node—Crohn's disease	6.74e-05	0.0095	CbGeAlD
Epinephrine—Renal impairment—Mesalazine—Crohn's disease	6.39e-05	0.0233	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	5.7e-05	0.0208	CcSEcCtD
Epinephrine—Memory impairment—Prednisone—Crohn's disease	5.65e-05	0.0206	CcSEcCtD
Epinephrine—Necrosis—Prednisone—Crohn's disease	5.65e-05	0.0206	CcSEcCtD
Epinephrine—Skin disorder—Mercaptopurine—Crohn's disease	5.35e-05	0.0195	CcSEcCtD
Epinephrine—Contusion—Prednisone—Crohn's disease	5.08e-05	0.0185	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	4.75e-05	0.0173	CcSEcCtD
Epinephrine—Haemoglobin—Azathioprine—Crohn's disease	4.64e-05	0.0169	CcSEcCtD
Epinephrine—Haemorrhage—Azathioprine—Crohn's disease	4.62e-05	0.0168	CcSEcCtD
Epinephrine—Renal failure—Mesalazine—Crohn's disease	4.61e-05	0.0168	CcSEcCtD
Epinephrine—Sweating—Mesalazine—Crohn's disease	4.49e-05	0.0164	CcSEcCtD
Epinephrine—Skin exfoliation—Prednisone—Crohn's disease	4.23e-05	0.0154	CcSEcCtD
Epinephrine—Haemoglobin—Mesalazine—Crohn's disease	4.23e-05	0.0154	CcSEcCtD
Epinephrine—Haemorrhage—Mesalazine—Crohn's disease	4.21e-05	0.0153	CcSEcCtD
Epinephrine—Arrhythmia—Azathioprine—Crohn's disease	4.13e-05	0.015	CcSEcCtD
Epinephrine—Pulmonary oedema—Prednisone—Crohn's disease	3.94e-05	0.0144	CcSEcCtD
Epinephrine—Mental disorder—Mesalazine—Crohn's disease	3.68e-05	0.0134	CcSEcCtD
Epinephrine—Erythema—Mesalazine—Crohn's disease	3.66e-05	0.0133	CcSEcCtD
Epinephrine—Tension—Mesalazine—Crohn's disease	3.59e-05	0.0131	CcSEcCtD
Epinephrine—Nervousness—Mesalazine—Crohn's disease	3.56e-05	0.013	CcSEcCtD
Epinephrine—Vomiting—Mercaptopurine—Crohn's disease	3.5e-05	0.0128	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	3.4e-05	0.0124	CcSEcCtD
Epinephrine—Nausea—Mercaptopurine—Crohn's disease	3.27e-05	0.0119	CcSEcCtD
Epinephrine—Palpitations—Mesalazine—Crohn's disease	3.24e-05	0.0118	CcSEcCtD
Epinephrine—Skin disorder—Azathioprine—Crohn's disease	3.19e-05	0.0116	CcSEcCtD
Epinephrine—Hypertension—Mesalazine—Crohn's disease	3.16e-05	0.0115	CcSEcCtD
Epinephrine—Psychotic disorder—Prednisone—Crohn's disease	3.14e-05	0.0115	CcSEcCtD
Epinephrine—Chest pain—Mesalazine—Crohn's disease	3.12e-05	0.0114	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	3.1e-05	0.0113	CcSEcCtD
Epinephrine—Nervous system disorder—Mesalazine—Crohn's disease	2.93e-05	0.0107	CcSEcCtD
Epinephrine—Hypokalaemia—Prednisone—Crohn's disease	2.93e-05	0.0107	CcSEcCtD
Epinephrine—Tachycardia—Mesalazine—Crohn's disease	2.92e-05	0.0106	CcSEcCtD
Epinephrine—Skin disorder—Mesalazine—Crohn's disease	2.9e-05	0.0106	CcSEcCtD
Epinephrine—Hyperhidrosis—Mesalazine—Crohn's disease	2.89e-05	0.0105	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Azathioprine—Crohn's disease	2.83e-05	0.0103	CcSEcCtD
Epinephrine—Sweating increased—Prednisone—Crohn's disease	2.71e-05	0.00987	CcSEcCtD
Epinephrine—Insomnia—Mesalazine—Crohn's disease	2.7e-05	0.00985	CcSEcCtD
Epinephrine—Paraesthesia—Mesalazine—Crohn's disease	2.68e-05	0.00978	CcSEcCtD
Epinephrine—Somnolence—Mesalazine—Crohn's disease	2.66e-05	0.00968	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Mesalazine—Crohn's disease	2.58e-05	0.0094	CcSEcCtD
Epinephrine—Hyperglycaemia—Prednisone—Crohn's disease	2.51e-05	0.00914	CcSEcCtD
Epinephrine—Acute coronary syndrome—Prednisone—Crohn's disease	2.44e-05	0.00891	CcSEcCtD
Epinephrine—Myocardial infarction—Prednisone—Crohn's disease	2.43e-05	0.00886	CcSEcCtD
Epinephrine—Haemoglobin—Prednisone—Crohn's disease	2.24e-05	0.00815	CcSEcCtD
Epinephrine—Haemorrhage—Prednisone—Crohn's disease	2.23e-05	0.00811	CcSEcCtD
Epinephrine—Hallucination—Prednisone—Crohn's disease	2.21e-05	0.00807	CcSEcCtD
Epinephrine—Dizziness—Azathioprine—Crohn's disease	2.17e-05	0.00791	CcSEcCtD
Epinephrine—Vomiting—Azathioprine—Crohn's disease	2.09e-05	0.0076	CcSEcCtD
Epinephrine—Flushing—Prednisone—Crohn's disease	2.07e-05	0.00753	CcSEcCtD
Epinephrine—Arrhythmia—Prednisone—Crohn's disease	1.99e-05	0.00725	CcSEcCtD
Epinephrine—Dizziness—Mesalazine—Crohn's disease	1.98e-05	0.0072	CcSEcCtD
Epinephrine—Mental disorder—Prednisone—Crohn's disease	1.95e-05	0.00711	CcSEcCtD
Epinephrine—Nausea—Azathioprine—Crohn's disease	1.95e-05	0.0071	CcSEcCtD
Epinephrine—Erythema—Prednisone—Crohn's disease	1.94e-05	0.00706	CcSEcCtD
Epinephrine—Vomiting—Mesalazine—Crohn's disease	1.9e-05	0.00692	CcSEcCtD
Epinephrine—Agitation—Prednisone—Crohn's disease	1.78e-05	0.00649	CcSEcCtD
Epinephrine—Nausea—Mesalazine—Crohn's disease	1.77e-05	0.00647	CcSEcCtD
Epinephrine—Hypertension—Prednisone—Crohn's disease	1.67e-05	0.0061	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	1.64e-05	0.00597	CcSEcCtD
Epinephrine—Nervous system disorder—Prednisone—Crohn's disease	1.55e-05	0.00565	CcSEcCtD
Epinephrine—Tachycardia—Prednisone—Crohn's disease	1.54e-05	0.00562	CcSEcCtD
Epinephrine—Skin disorder—Prednisone—Crohn's disease	1.54e-05	0.0056	CcSEcCtD
Epinephrine—Hyperhidrosis—Prednisone—Crohn's disease	1.53e-05	0.00557	CcSEcCtD
Epinephrine—Insomnia—Prednisone—Crohn's disease	1.43e-05	0.00521	CcSEcCtD
Epinephrine—Paraesthesia—Prednisone—Crohn's disease	1.42e-05	0.00517	CcSEcCtD
Epinephrine—Dizziness—Prednisone—Crohn's disease	1.05e-05	0.00381	CcSEcCtD
Epinephrine—ADRBK1—Disease—PTGS2—Crohn's disease	1.03e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	1.03e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RBX1—Crohn's disease	1.02e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CCR6—Crohn's disease	1.02e-05	0.000154	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	1.02e-05	0.000154	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	1.02e-05	0.000153	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—MTMR3—Crohn's disease	1.02e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL2RA—Crohn's disease	1.01e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CCR6—Crohn's disease	1.01e-05	0.000152	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL2RA—Crohn's disease	1.01e-05	0.000152	CbGpPWpGaD
Epinephrine—Vomiting—Prednisone—Crohn's disease	1.01e-05	0.00366	CcSEcCtD
Epinephrine—ADRA2B—GPCR downstream signaling—IL2RA—Crohn's disease	1e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR ligand binding—CXCL8—Crohn's disease	1e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—PTGER4—Crohn's disease	9.98e-06	0.000151	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	9.96e-06	0.00015	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—JAK2—Crohn's disease	9.95e-06	0.00015	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL2RA—Crohn's disease	9.89e-06	0.000149	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—SMAD3—Crohn's disease	9.87e-06	0.000149	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	9.85e-06	0.000149	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	9.56e-06	0.000144	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—STAT3—Crohn's disease	9.54e-06	0.000144	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	9.53e-06	0.000144	CbGpPWpGaD
Epinephrine—SLC22A2—Transmembrane transport of small molecules—ALB—Crohn's disease	9.53e-06	0.000144	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—CXCL8—Crohn's disease	9.49e-06	0.000143	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CCR6—Crohn's disease	9.41e-06	0.000142	CbGpPWpGaD
Epinephrine—Nausea—Prednisone—Crohn's disease	9.39e-06	0.00342	CcSEcCtD
Epinephrine—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	9.36e-06	0.000141	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RBX1—Crohn's disease	9.34e-06	0.000141	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	9.25e-06	0.00014	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL2RA—Crohn's disease	9.21e-06	0.000139	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL2RA—Crohn's disease	9.18e-06	0.000139	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL2RA—Crohn's disease	9.14e-06	0.000138	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RBX1—Crohn's disease	9.13e-06	0.000138	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	9.1e-06	0.000137	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—PTGER4—Crohn's disease	9.09e-06	0.000137	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	9.01e-06	0.000136	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—UBE2D1—Crohn's disease	8.99e-06	0.000136	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL2RA—Crohn's disease	8.98e-06	0.000136	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—PTGER4—Crohn's disease	8.89e-06	0.000134	CbGpPWpGaD
Epinephrine—SLC22A1—Transmembrane transport of small molecules—ALB—Crohn's disease	8.88e-06	0.000134	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	8.88e-06	0.000134	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	8.85e-06	0.000133	CbGpPWpGaD
Epinephrine—PAH—Disease—IL6—Crohn's disease	8.79e-06	0.000133	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RIPK2—Crohn's disease	8.71e-06	0.000131	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—ALB—Crohn's disease	8.7e-06	0.000131	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—STAT3—Crohn's disease	8.68e-06	0.000131	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—MTMR3—Crohn's disease	8.68e-06	0.000131	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	8.64e-06	0.00013	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RBX1—Crohn's disease	8.51e-06	0.000128	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	8.5e-06	0.000128	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL3—Crohn's disease	8.5e-06	0.000128	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	8.41e-06	0.000127	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL2RA—Crohn's disease	8.36e-06	0.000126	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	8.35e-06	0.000126	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—PTGER4—Crohn's disease	8.28e-06	0.000125	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	8.25e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—RASGRP1—Crohn's disease	8.22e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—UBE2D1—Crohn's disease	8.19e-06	0.000124	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	8.18e-06	0.000123	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	8.11e-06	0.000122	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—JAK2—Crohn's disease	8.08e-06	0.000122	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TYK2—Crohn's disease	8.02e-06	0.000121	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—STAT3—Crohn's disease	8.02e-06	0.000121	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—UBE2D1—Crohn's disease	8.01e-06	0.000121	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RIPK2—Crohn's disease	7.94e-06	0.00012	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—FADS1—Crohn's disease	7.91e-06	0.000119	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	7.88e-06	0.000119	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	7.87e-06	0.000119	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RIPK2—Crohn's disease	7.77e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	7.76e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL3—Crohn's disease	7.74e-06	0.000117	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL3—Crohn's disease	7.67e-06	0.000116	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—JAK2—Crohn's disease	7.65e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	7.6e-06	0.000115	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	7.58e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL3—Crohn's disease	7.57e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	7.56e-06	0.000114	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—RASGRP1—Crohn's disease	7.49e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—UBE2D1—Crohn's disease	7.46e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—JAK2—Crohn's disease	7.46e-06	0.000113	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SOCS1—Crohn's disease	7.45e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	7.43e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	7.42e-06	0.000112	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GPX4—Crohn's disease	7.41e-06	0.000112	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	7.36e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	7.35e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—RASGRP1—Crohn's disease	7.33e-06	0.000111	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RIPK2—Crohn's disease	7.23e-06	0.000109	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL3—Crohn's disease	7.17e-06	0.000108	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GCKR—Crohn's disease	7.16e-06	0.000108	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—TYK2—Crohn's disease	7.1e-06	0.000107	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL3—Crohn's disease	7.05e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	7.02e-06	0.000106	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—CXCL8—Crohn's disease	6.98e-06	0.000105	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	6.93e-06	0.000105	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	6.9e-06	0.000104	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	6.83e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RASGRP1—Crohn's disease	6.82e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—GPCR downstream signaling—CXCL8—Crohn's disease	6.81e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—JAK2—Crohn's disease	6.8e-06	0.000103	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SOCS1—Crohn's disease	6.78e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—JAK2—Crohn's disease	6.77e-06	0.000102	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—FADS1—Crohn's disease	6.76e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	6.73e-06	0.000102	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	6.72e-06	0.000101	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—MTMR3—Crohn's disease	6.7e-06	0.000101	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—IL6—Crohn's disease	6.66e-06	0.000101	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—JAK2—Crohn's disease	6.65e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—IL6—Crohn's disease	6.64e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SOCS1—Crohn's disease	6.64e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	6.62e-06	0.0001	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—TYK2—Crohn's disease	6.47e-06	9.76e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TYK2—Crohn's disease	6.44e-06	9.71e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SMAD3—Crohn's disease	6.43e-06	9.7e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	6.42e-06	9.69e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	6.41e-06	9.67e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GPX4—Crohn's disease	6.33e-06	9.55e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—TYK2—Crohn's disease	6.33e-06	9.55e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	6.29e-06	9.49e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	6.28e-06	9.47e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL3—Crohn's disease	6.26e-06	9.45e-05	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—CXCL8—Crohn's disease	6.2e-06	9.36e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—JAK2—Crohn's disease	6.19e-06	9.34e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—CXCL8—Crohn's disease	6.18e-06	9.33e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SOCS1—Crohn's disease	6.18e-06	9.32e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—JAK2—Crohn's disease	6.17e-06	9.31e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	6.16e-06	9.29e-05	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	6.15e-06	9.27e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—JAK2—Crohn's disease	6.14e-06	9.27e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GCKR—Crohn's disease	6.12e-06	9.23e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	6.11e-06	9.23e-05	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—CXCL8—Crohn's disease	6.07e-06	9.15e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—IL6—Crohn's disease	6.07e-06	9.15e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	6.06e-06	9.14e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—JAK2—Crohn's disease	6.04e-06	9.11e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	5.99e-06	9.03e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	5.97e-06	9.01e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL2RA—Crohn's disease	5.95e-06	8.98e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—TYK2—Crohn's disease	5.89e-06	8.89e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SMAD3—Crohn's disease	5.86e-06	8.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL3—Crohn's disease	5.82e-06	8.78e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	5.8e-06	8.76e-05	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	5.74e-06	8.66e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SMAD3—Crohn's disease	5.73e-06	8.65e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	5.71e-06	8.62e-05	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—CXCL8—Crohn's disease	5.65e-06	8.52e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—CXCL8—Crohn's disease	5.63e-06	8.5e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	5.63e-06	8.49e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—JAK2—Crohn's disease	5.62e-06	8.48e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—STAT3—Crohn's disease	5.62e-06	8.47e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—CXCL8—Crohn's disease	5.61e-06	8.46e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—IL6—Crohn's disease	5.6e-06	8.45e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	5.58e-06	8.42e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—CXCL8—Crohn's disease	5.51e-06	8.31e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	5.5e-06	8.3e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	5.49e-06	8.28e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL2RA—Crohn's disease	5.42e-06	8.18e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	5.42e-06	8.18e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	5.37e-06	8.11e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SMAD3—Crohn's disease	5.34e-06	8.05e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—IL6—Crohn's disease	5.33e-06	8.04e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL2RA—Crohn's disease	5.31e-06	8.01e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	5.23e-06	7.9e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—FADS1—Crohn's disease	5.22e-06	7.87e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	5.21e-06	7.87e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—CXCL8—Crohn's disease	5.13e-06	7.74e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.11e-06	7.72e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	5.11e-06	7.71e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	5.1e-06	7.7e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	5.02e-06	7.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	5.02e-06	7.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	4.99e-06	7.53e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL2RA—Crohn's disease	4.94e-06	7.45e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GPX4—Crohn's disease	4.89e-06	7.37e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	4.86e-06	7.34e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	4.74e-06	7.15e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GCKR—Crohn's disease	4.72e-06	7.12e-05	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	4.66e-06	7.04e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	4.64e-06	7e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	4.56e-06	6.88e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—STAT3—Crohn's disease	4.51e-06	6.8e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.47e-06	6.75e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ALB—Crohn's disease	4.46e-06	6.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	4.4e-06	6.64e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	4.39e-06	6.62e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	4.37e-06	6.59e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ALB—Crohn's disease	4.34e-06	6.55e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	4.23e-06	6.39e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TYK2—Crohn's disease	4.19e-06	6.33e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ALB—Crohn's disease	4.16e-06	6.28e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	4.08e-06	6.15e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—JAK2—Crohn's disease	4e-06	6.04e-05	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IL6—Crohn's disease	3.92e-06	5.92e-05	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—Crohn's disease	3.9e-06	5.89e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	3.82e-06	5.77e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TYK2—Crohn's disease	3.82e-06	5.77e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—Crohn's disease	3.8e-06	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	3.79e-06	5.71e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TYK2—Crohn's disease	3.74e-06	5.64e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—CXCL8—Crohn's disease	3.65e-06	5.51e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—JAK2—Crohn's disease	3.65e-06	5.5e-05	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—Crohn's disease	3.64e-06	5.49e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	3.61e-06	5.45e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—JAK2—Crohn's disease	3.57e-06	5.38e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	3.54e-06	5.34e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ALB—Crohn's disease	3.53e-06	5.32e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TYK2—Crohn's disease	3.48e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL6—Crohn's disease	3.47e-06	5.24e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	3.37e-06	5.09e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—CXCL8—Crohn's disease	3.33e-06	5.02e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—JAK2—Crohn's disease	3.32e-06	5.01e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	3.3e-06	4.97e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—CXCL8—Crohn's disease	3.25e-06	4.91e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL6—Crohn's disease	3.16e-06	4.77e-05	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL6—Crohn's disease	3.15e-06	4.75e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	3.13e-06	4.73e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL6—Crohn's disease	3.09e-06	4.67e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	3.09e-06	4.67e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—Crohn's disease	3.08e-06	4.65e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	3.08e-06	4.65e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—CXCL8—Crohn's disease	3.03e-06	4.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	2.95e-06	4.45e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—STAT3—Crohn's disease	2.94e-06	4.43e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	2.93e-06	4.42e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL6—Crohn's disease	2.88e-06	4.35e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	2.87e-06	4.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	2.74e-06	4.14e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	2.69e-06	4.06e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—STAT3—Crohn's disease	2.68e-06	4.04e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	2.65e-06	4e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—STAT3—Crohn's disease	2.62e-06	3.95e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	2.56e-06	3.86e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	2.5e-06	3.77e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	2.48e-06	3.74e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—STAT3—Crohn's disease	2.44e-06	3.68e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	2.38e-06	3.59e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ALB—Crohn's disease	2.28e-06	3.44e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	2.17e-06	3.27e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL6—Crohn's disease	2.05e-06	3.09e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	2.01e-06	3.04e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—Crohn's disease	1.99e-06	3.01e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ALB—Crohn's disease	1.95e-06	2.94e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL6—Crohn's disease	1.87e-06	2.82e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL6—Crohn's disease	1.85e-06	2.79e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL6—Crohn's disease	1.83e-06	2.76e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL6—Crohn's disease	1.73e-06	2.61e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.7e-06	2.57e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL6—Crohn's disease	1.7e-06	2.57e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL6—Crohn's disease	1.51e-06	2.28e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ALB—Crohn's disease	1.5e-06	2.27e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL6—Crohn's disease	1.41e-06	2.12e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.31e-06	1.98e-05	CbGpPWpGaD
